4.7 Article

A pan-cancer analysis shows immunoevasive characteristics in NRF2 hyperactive squamous malignancies

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Oncology

NRF2 Activation Promotes Aggressive Lung Cancer and Associates with Poor Clinical Outcomes

Anju Singh et al.

Summary: Genomic alterations in KEAP1 and NFE2L2 lead to stabilization of the transcription factor NRF2 in a significant proportion of lung adenocarcinoma and squamous cell carcinoma patients. Experiments in genetically engineered mouse models reveal the oncogenic role of NRF2, particularly in promoting aggressive lung adenocarcinoma and affecting treatment responses. The NRF2 activation signature is associated with poor prognosis and limited response to anti-PD-L1 treatment in patients with nonsquamous or squamous tumors.

CLINICAL CANCER RESEARCH (2021)

Article Cell Biology

NAD+ Metabolism Maintains Inducible PD-L1 Expression to Drive Tumor Immune Evasion

Hongwei Lv et al.

Summary: The study reveals that NAMPT enzyme drives PD-L1 expression in various tumors and governs tumor immune evasion through CD8(+) T cell regulation. NAD(+) metabolism maintains the activity and expression of Tet1, which plays a critical role in PD-L1 expression on tumors.

CELL METABOLISM (2021)

Review Oncology

Oxidative Stress in Cancer

John D. Hayes et al.

CANCER CELL (2020)

Review Oncology

SOX2 and squamous cancers

Linsey Porter et al.

SEMINARS IN CANCER BIOLOGY (2020)

Review Oncology

Turning Cold into Hot: Firing up the Tumor Microenvironment

Qianqian Duan et al.

TRENDS IN CANCER (2020)

Article Biochemical Research Methods

TISIDB: an integrated repository portal for tumor-immune system interactions

Beibei Ru et al.

BIOINFORMATICS (2019)

Article Biochemistry & Molecular Biology

WNT signaling modulates PD-L1 expression in the stem cell compartment of triple-negative breast cancer

Lorenzo Castagnoli et al.

ONCOGENE (2019)

Article Multidisciplinary Sciences

CD8+ T cells regulate tumour ferroptosis during cancer immunotherapy

Weimin Wang et al.

NATURE (2019)

Article Biochemistry & Molecular Biology

Nrf2 and SQSTM1/p62 jointly contribute to mesenchymal transition and invasion in glioblastoma

Petri Polonen et al.

ONCOGENE (2019)

Article Genetics & Heredity

PD-L1 Testing in Guiding Patient Selection for PD-1/PD-L1 Inhibitor Therapy in Lung Cancer

Katerina Ancevski Hunter et al.

MOLECULAR DIAGNOSIS & THERAPY (2018)

Review Oncology

NRF2 and the Hallmarks of Cancer

Montserrat Rojo de la Vega et al.

CANCER CELL (2018)

Article Immunology

The Immune Landscape of Cancer

Vesteinn Thorsson et al.

IMMUNITY (2018)

Review Oncology

Impact of oncogenic pathways on evasion of antitumour immune responses

Stefani Spranger et al.

NATURE REVIEWS CANCER (2018)

Article Biochemistry & Molecular Biology

Analysis of primary microRNA loci from nascent transcriptomes reveals regulatory domains governed by chromatin architecture

Maria Bouvy-Liivrand et al.

NUCLEIC ACIDS RESEARCH (2017)

Article Multidisciplinary Sciences

QuPath: Open source software for digital pathology image analysis

Peter Bankhead et al.

SCIENTIFIC REPORTS (2017)

Article Multidisciplinary Sciences

MYC regulates the antitumor immune response through CD47 and PD-L1

Stephanie C. Casey et al.

SCIENCE (2016)

Review Oncology

Classifying Cancers Based on T-cell Infiltration and PD-L1

Michele W. L. Teng et al.

CANCER RESEARCH (2015)

Article Biochemical Research Methods

Robust enumeration of cell subsets from tissue expression profiles

Aaron M. Newman et al.

NATURE METHODS (2015)

Review Biochemistry & Molecular Biology

The Nrf2 regulatory network provides an interface between redox and intermediary metabolism

John D. Hayes et al.

TRENDS IN BIOCHEMICAL SCIENCES (2014)

Review Biochemistry & Molecular Biology

The Keap1-Nrf2 pathway: Mechanisms of activation and dysregulation in cancer

Emilia Kansanen et al.

REDOX BIOLOGY (2013)

Article Biochemical Research Methods

Fiji: an open-source platform for biological-image analysis

Johannes Schindelin et al.

NATURE METHODS (2012)

Review Biochemistry & Molecular Biology

Hallmarks of Cancer: The Next Generation

Douglas Hanahan et al.